Literature DB >> 23880953

Statins for primary prevention: identifying low-risk individuals.

Yu-li Huang, Yi Huang, Yan-xian Wu.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23880953     DOI： 10.1038/nrcardio.2013.80-c1

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  11 in total

1.  Statins for all by the age of 50 years?

Authors:  Shah Ebrahim; Juan P Casas
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321

Review 2.  Statins in the primary prevention of cardiovascular disease.

Authors:  Željko Reiner
Journal:  Nat Rev Cardiol       Date:  2013-06-04       Impact factor: 32.419

Review 3.  Cardiovascular disease prevention: matching evidence-based algorithms with individualized care.

Authors:  R Madanieh; R K Hasan; O F Anusionwu; R S Blumenthal; M J Blaha
Journal:  Clin Pharmacol Ther       Date:  2013-01-16       Impact factor: 6.875

4.  Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial.

Authors:  Yadon Arad; Louise A Spadaro; Marguerite Roth; David Newstein; Alan D Guerci
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

5.  Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study.

Authors:  Michael J Blaha; Matthew J Budoff; Andrew P DeFilippis; Ron Blankstein; Juan J Rivera; Arthur Agatston; Daniel H O'Leary; Joao Lima; Roger S Blumenthal; Khurram Nasir
Journal:  Lancet       Date:  2011-08-20       Impact factor: 79.321

Review 6.  Statins for the primary prevention of cardiovascular disease.

Authors:  Fiona Taylor; Kirsten Ward; Theresa Hm Moore; Margaret Burke; George Davey Smith; Juan-Pablo Casas; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

7.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  N Engl J Med       Date:  2008-11-09       Impact factor: 91.245

8.  Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA).

Authors:  Susan G Lakoski; Philip Greenland; Nathan D Wong; Pamela J Schreiner; David M Herrington; Richard A Kronmal; Kiang Liu; Roger S Blumenthal
Journal:  Arch Intern Med       Date:  2007-12-10

9.  Improving vascular health: are pills the answer?

Authors:  Liam Smeeth; Harry Hemingway
Journal:  BMJ       Date:  2012-05-31

10.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

Authors:  B Mihaylova; J Emberson; L Blackwell; A Keech; J Simes; E H Barnes; M Voysey; A Gray; R Collins; C Baigent
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321
View more
  1 in total

1.  Statins for primary prevention: problems with cardiovascular-risk estimation?

Authors:  Željko Reiner
Journal:  Nat Rev Cardiol       Date:  2013-07-23       Impact factor: 32.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.